Advancing care through smart innovation
Revesta Health Care Limited (RHCL) is an ISO 9001:2015 certified Indian pharmaceutical company dedicated to delivering life-saving medical solutions—right when they’re needed most. Based in Kolkata, RHCL specializes in critical care injectables while continuously innovating for the future of healthcare. Driven by compassion, precision, and courage, we are committed to transforming patient lives and building a healthier world.
RHCL is a fast-growing, 6-year-old pharmaceutical company specializing in the manufacturing of critical care and oral care medicines. With a strong focus on quality, innovation, and affordability, RHCL delivers effective healthcare solutions designed to improve patient outcomes. Backed by modern manufacturing practices and a commitment to excellence, the company continues to expand its presence in the healthcare sector.
“It is health that is the real wealth, and not pieces of gold and silver.”
RHCL offers a comprehensive range of critical care medicines designed to support life-saving treatments in emergency and intensive care settings. Our advanced injectable formulations ensure high efficacy, safety, and rapid action, helping healthcare professionals manage severe and complex medical conditions with confidence. Committed to quality and affordability, RHCL delivers reliable solutions that improve patient outcomes when it matters most.
Oral care is essential to overall health, and at RHCL, we are committed to delivering advanced, effective, and reliable oral care medicines. Our range is carefully developed to support the prevention and treatment of common dental and oral conditions such as gum infections, mouth ulcers, sensitivity, and plaque buildup. Backed by research and stringent quality standards, RHCL’s oral care solutions ensure optimal hygiene, faster relief, and long-lasting protection.
RHCL envisions revitalizing healthcare by delivering high-quality critical care injectables to the medical community. We are committed to providing safe, effective, and affordable medicines to treat critical illnesses and improve patient outcomes.
Mus nullam dis blandit metus. Suscipit duis class efficitur nam. Pharetra velit imperdiet fames senectus dis dictumst porta. Auctor phasellus placerat torquent ridiculus justo mus habitasse. Accumsan magna dictum malesuada leo elit. Orci fermentum maecenas hac purus mattis ex tempor. Est nisl nascetur duis.
Potenti ridiculus eros nam nisl nunc. Tortor si felis lorem aliquet cras sit sagittis. Suscipit eros conubia tempus. Dictumst erat taciti ultricies potenti vitae. Fringilla eu vitae nostra vestibulum rhoncus himenaeos diam. Laoreet lacus neque felis.
